Estrogen receptor-α mRNA variants in murine and human tissues

Molecular and Cellular Endocrinology

Volumn 158, Issue 1-2, 1999, Pages 153-161

  Lu, Biao ^a   Dotzlaw, Helmut ^a   Leygue, Etienne ^a   Murphy, Liam J ^a   Watson, Peter H ^a   Murphy, Leigh C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alternative splicing; Estrogen receptor ; Species differences; Variant mRNAs

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; BREAST; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OVARY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; UTERUS;

ALTERNATIVE SPLICING; ANIMALS; ESTROGEN RECEPTOR ALPHA; EXONS; FEMALE; HUMANS; MICE; ORGAN SPECIFICITY; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 0032693902     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00169-0     Document Type: Article

References (36)

1. Balvay L., Pret A.-M., Libri D., Helfman D., Fiszman M. Splicing of the alternative exons of chicken, rat and Xenopus β tropomyosin transcripts requires class-specific elements. J. Biol. Chem. 269:1994;19675-19678.
2. Conboy J., Cox T., Bottomley S., Bawden M., May B. Human erythroid 5-aminolevulinate synthase: gene structure and species-specific differences in alternative RNA splicing. J. Biol. Chem. 267:1992;18753-18758.
3. Cooper T., Mattox W. The regulation of splice-site selection, and its role in human disease. Am. J. Hum. Genet. 61:1997;259-266.
4. Coulter L., Landree M., Cooper T. Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell. Biol. 17:1997;2143-2150.
5. Couse J., Curtis S., Washburn T., Lindzey J., Golding T., Lubahn D. et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9:1995;1441-1454.
6. Curtis S., Shi H., Teng C., Korach K. Promoter and species-specific differential estrogen mediated gene transcription in the uterus and cultured cells using structurally altered agonists. J. Mol. Endocrinol. 18:1997;203-211.
7. Dotzlaw H., Miller T., Karvelas J., Murphy L.C. Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res. 50:1990;4204-4208.
8. Dotzlaw H., Leygue E., Watson P., Murphy L. Expression of estrogen receptor-beta in human breast tumors. J. Clin. Endocrinol. Metabol. 82:1997;2371-2374.
9. Erenburg I., Schachter B., Lopez R.M.y., Ossowski L. Loss of an estrogen receptor isoform (ER-alpha deleted 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation. Mol. Endocrinol. 11:1997;2004-2015.
10. Fulop C., Cs-szabo G., Glant T. Species-specific alternative splicing of the epidermal growth factor-like domain 1 of cartilage aggrecan. Biochem. J. 319:1996;935-940.
11. Green S., Walter P., Kumar V., Krust A., Bornert J., Argos P. Human estrogen receptor cDNA: sequence, expression, and homology to v-erb-A. Nature. 320:1986;134-139.
12. Hendriks W., Weetink H., Voorter C., Sanders J., Bloemendal H., Jong W.d. The alternative splicing product αAins-crystallin is structurally equivalent to αA and αB subunits in the rat- α-crystallin aggregate. Biochim. Biophys. Acta. 1037:1990;58-65.
13. Hirano F., Chung M., Tanaka H., Maruyama N., Makino I., Moore D. et al. Alternative splicing variants of IκBβ establish differential NF-κB signal responsiveness in human cells. Mol. Cell. Biol. 18:1998;2596-2607.
14. Hoshino S., Inoue S., Hosoi T., Saito T., Ikegami A., Kaneki M. et al. Demonstration of isoforms of the estrogen receptor in the bone tissues and in osteoblastic cells. Calcif. Tissue Int. 57:1995;466-468.
15. Inoue S., Hoshino S., Miyoshi H., Akishita M., Hosoi T., Orimo H. et al. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 219:1996;766-772.
16. Laurell H., Grober J., Vindis C., Lacombe T., Dauzats M., Holm C. et al. Species-specific alternative splicing generates a catalytically inactive form of human hormone sensitive lipase. Biochem. J. 328:1997;137-143.
17. Leygue E., Huang A., Murphy L., Watson P. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res. 56:1996;4324-4327.
18. Leygue E., Murphy L., Kuttenn F., Watson P. Triple primer polymerase chain reaction: a new way to quantify truncated mRNA expression. Am. J. Pathol. 148:1996;1097-1103.
19. Leygue E.R., Watson P.H., Murphy L.C. Estrogen receptor variants in normal human mammary tissue. J. Natl. Cancer Inst. 88:1996;284-290.
20. Lu B., Leygue E., Dotzlaw H., Murphy L., Murphy L., Watson P. Estrogen receptor-beta mRNA variants in human and murine tissues. Mol. Cell. Endocrinol. 138:1998;199-203.
21. Manley J., Tacke R. SR proteins and splicing control. Genes. Dev. 10:1996;1569-1579.
22. Martin L., Middleton E. Prolonged oestrogenic and mitogenic activity of tamoxifen in the ovariectomized mouse. J. Endocrinol. 78:1978;125-129.
23. Morrison M., Harris K., Roth M. smg mutants affect the expression of alternatively spliced SR protein mRNAs in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 94:1997;9782-9785.
24. Murphy L.C., Dotzlaw H. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol. Endocrinol. 3:1989;687-693.
25. Murphy L., Leygue E., Dotzlaw H., Douglas D., Coutts A., Watson P. Oestrogen receptor variants and mutations in human breast cancer. Ann. Med. 29:1997;221-234.
26. Murphy L., Dotzlaw H., Leygue E., Douglas D., Coutts A., Watson P. Estrogen receptor variants and mutations: a review. J. Steroid Biochem. Mol. Biol. 62:1997;363-372.
27. Oakley R., Sar M., Cidlowski J. The human glucocorticoid receptor isoform: expression, biochemical properties, and putative function. J. Biol. Chem. 271:1996;9550-9559.
28. Oakley R., Webster J., Sar M., Jr C.P., Cidlowski J. Expression and subcellular distribution of the β-isoform of the human glucocorticoid receptor. Endocrinology. 138:1997;5028-5038.
29. Otto C., Reichardt H., Schutz G. Absence of glucocorticoid receptor-beta in mice. J. Biol. Chem. 272:1997;26665-26668.
30. Ponglikitmongkol M., Green S., Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO. J. 7:1988;8885-8888.
31. Rey J., Pujol P., Dechaud H., Edouard E., Hedon B., Maudelonde T. Expression of oestrogen receptor-alpha splicing variants and oestrogen receptor-beta in endometrium of infertile patients. Mol. Hum. Reprod. 4:1998;641-647.
32. Rice L.W., Jazaeri A.A., Shupnik M.A. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma. Gynecol. Oncol. 65:1997;149-157.
33. Skipper J.K., Young L.J., Bergeron J.M., Tetzlaff M.T., Osborn C.T., Crews D. Identification of an isoform of the estrogen receptor messenger RNA lacking exon four present in the brain. Proc. Natl. Acad. Sci. USA. 90:1993;7172-7175.
34. White R., Lees J., Needham M., Parker M. Structural organization and expression of the mouse estrogen receptor. Mol. Endocrinol. 1:1987;735-744.
35. Will K., Warnecke G., Bergmann S., Deppert W. Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53. Nucleic. Acid. Res. 23:1995;4023-4028.
36. Xu C., Chambers J., Solomon E. Complex regulation of the BRCA1 gene. J. Biol. Chem. 272:1997;20994-20997.